Predicting Pharmacokinetics of Drugs Using Artificial Intelligence Tools: A Systematic Review

被引:2
作者
Ahmadi, Mahnaz [1 ,2 ]
Alizadeh, Bahareh [3 ]
Ayyoubzadeh, Seyed Mohammad [4 ,5 ]
Abiyarghamsari, Mahdiye [6 ]
机构
[1] Shahid Beheshti Univ Med Sci, Student Res Comm, Sch Pharm, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Med Nanotechnol & Tissue Engn Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Prot Technol Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Allied Med Sci, Dept Hlth Informat Management, Tehran, Iran
[5] Univ Tehran Med Sci, Hlth Informat Management Res Ctr, Tehran, Iran
[6] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Clin Pharm, Tehran 1991953381, Iran
关键词
CLEARANCE;
D O I
10.1007/s13318-024-00883-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and objectivePharmacokinetic studies encompass the examination of the absorption, distribution, metabolism, and excretion of bioactive compounds. The pharmacokinetics of drugs exert a substantial influence on their efficacy and safety. Consequently, the investigation of pharmacokinetics holds great importance. However, laboratory-based assessment necessitates the use of numerous animals, various materials, and significant time. To mitigate these challenges, alternative methods such as artificial intelligence have emerged as a promising approach. This systematic review aims to review existing studies, focusing on the application of artificial intelligence tools in predicting the pharmacokinetics of drugs.MethodsA pre-prepared search strategy based on related keywords was used to search different databases (PubMed, Scopus, Web of Science). The process involved combining articles, eliminating duplicates, and screening articles based on their titles, abstracts, and full text. Articles were selected based on inclusion and exclusion criteria. Then, the quality of the included articles was assessed using an appraisal tool.ResultsUltimately, 23 relevant articles were included in this study. The clearance parameter received the highest level of investigation, followed by the area under the concentration-time curve (AUC) parameter, in pharmacokinetic studies. Among the various models employed in the articles, Random Forest and eXtreme Gradient Boosting (XGBoost) emerged as the most commonly utilized ones. Generalized Linear Models and Elastic Nets (GLMnet) and Random Forest models showed the most performance in predicting clearance.ConclusionOverall, artificial intelligence tools offer a robust, rapid, and precise means of predicting various pharmacokinetic parameters based on a dataset containing information of patients or drugs.
引用
收藏
页码:249 / 262
页数:14
相关论文
共 47 条
  • [1] A machine learning-based approach to ERα bioactivity and drug ADMET prediction
    An, Tianbo
    Chen, Yueren
    Chen, Yefeng
    Ma, Leyu
    Wang, Jingrui
    Zhao, Jian
    [J]. FRONTIERS IN GENETICS, 2023, 13
  • [2] Drug metabolism and pharmacokinetics
    Benedetti, Margherita Strolin
    Whomsley, Rhys
    Poggesi, Italo
    Cawello, Willi
    Mathy, Francois-Xavier
    Delporte, Marie-Laure
    Papeleu, Peggy
    Watelet, Jean-Baptiste
    [J]. DRUG METABOLISM REVIEWS, 2009, 41 (03) : 344 - 390
  • [3] Predicting drug properties with parameter-free machine learning: pareto-optimal embedded modeling (POEM)
    Brereton, Andrew E.
    MacKinnon, Stephen
    Safikhani, Zhaleh
    Reeves, Shawn
    Alwash, Sana
    Shahani, Vijay
    Windemuth, Andreas
    [J]. MACHINE LEARNING-SCIENCE AND TECHNOLOGY, 2020, 1 (02):
  • [4] XGBoost: A Scalable Tree Boosting System
    Chen, Tianqi
    Guestrin, Carlos
    [J]. KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, 2016, : 785 - 794
  • [5] The coefficient of determination R-squared is more informative than SMAPE, MAE, MAPE, MSE and RMSE in regression analysis evaluation
    Chicco, Davide
    Warrens, Matthijs J.
    Jurman, Giuseppe
    [J]. PEERJ COMPUTER SCIENCE, 2021,
  • [6] MACHINE LEARNING-BASED VIRTUAL SCREENING, MOLECULAR DOCKING, DRUG-LIKENESS, PHARMACOKINETICS AND TOXICITY ANALYSES TO IDENTIFY NEW NATURAL INHIBITORS OF THE GLYCOPROTEIN SPIKE (S1) OF SARS-CoV-2
    Cobre, Alexandre de F.
    Boeger, Beatriz
    Fachi, Mariana M.
    Ehrenfried, Carlos A.
    Stremel, Dile P.
    De Melo, Eduardo B.
    Tonin, Fernanda S.
    Pontarolo, Roberto
    [J]. QUIMICA NOVA, 2023, 46 (05): : 450 - 459
  • [7] A decade of machine learning-based predictive models for human pharmacokinetics: Advances and challenges
    Danishuddin
    Kumar, Vikas
    Faheem, Mohammad
    Lee, Keun Woo
    [J]. DRUG DISCOVERY TODAY, 2022, 27 (02) : 529 - 537
  • [8] A Hybrid Algorithm Combining Population Pharmacokinetic and Machine Learning for Isavuconazole Exposure Prediction
    Destere, Alexandre
    Marquet, Pierre
    Labriffe, Marc
    Drici, Milou-Daniel
    Woillard, Jean-Baptiste
    [J]. PHARMACEUTICAL RESEARCH, 2023, 40 (04) : 951 - 959
  • [9] A Hybrid Model Associating Population Pharmacokinetics with Machine Learning: A Case Study with Iohexol Clearance Estimation
    Destere, Alexandre
    Marquet, Pierre
    Gandonniere, Charlotte Salmon
    Asberg, Anders
    Loustaud-Ratti, Veronique
    Carrier, Paul
    Ehrmann, Stephan
    Barin-Le Guellec, Chantal
    Premaud, Aurelie
    Woillard, Jean-Baptiste
    [J]. CLINICAL PHARMACOKINETICS, 2022, 61 (08) : 1157 - 1165
  • [10] ADME/PK as part of a rational approach to drug discovery
    Eddershaw, PJ
    Beresford, AP
    Bayliss, MK
    [J]. DRUG DISCOVERY TODAY, 2000, 5 (09) : 409 - 414